Linoleic Acid-Rich Oil for Sarcopenia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a daily dose of linoleic acid-rich oil might benefit older adults with sarcopenia, a condition characterized by weaker and smaller muscles. The researchers aim to determine if this oil can enhance muscle strength, size, stamina, and movement. Participants will consume either oil rich in linoleic acid or a placebo oil with oleic acid. This trial suits individuals with probable sarcopenia who typically consume less linoleic acid than recommended. As an unphased study, it offers a unique opportunity to contribute to understanding how dietary changes might improve muscle health in older adults.
Will I have to stop taking my current medications?
The trial requires that you stop using supplements or medications for weight loss and blood thinner medications. If you are taking these, you will need to stop before participating.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that high linoleic safflower oil is generally safe to eat, although specific safety data for humans is limited. Linoleic acid, an omega-6 fatty acid found in many food oils, has been part of diets for a long time. Some studies suggest that consuming linoleic acid may offer health benefits, such as reducing the risk of certain diseases. However, concerns exist that excessive intake might increase the risk of issues like skin cancer.
For high oleic safflower oil, used as a placebo in this trial, specific safety data is unavailable. However, its common use in cooking suggests it is generally well-tolerated.
Overall, both types of safflower oil are regularly consumed in everyday diets, and no major safety concerns have been noted for typical use. However, individual reactions can vary.12345Why are researchers excited about this trial's treatments?
Researchers are excited about using high linoleic safflower oil for sarcopenia because it offers a fresh approach to muscle health. Unlike standard treatments that often focus on exercise and protein supplementation, this oil leverages linoleic acid, a natural component, to potentially enhance muscle mass and strength. The simplicity of consuming just 12 grams of this oil daily could make it an easy addition to daily routines, offering a novel dietary intervention to combat muscle loss.
What evidence suggests that this trial's treatments could be effective for sarcopenia?
Research has shown that linoleic acid, found in high linoleic safflower oil, might improve muscle function. Participants in this trial will receive high linoleic safflower oil to evaluate its effects on muscle health. Studies suggest it can enhance mitochondrial function, crucial for energy production in cells. This improvement could strengthen muscles, particularly in older adults experiencing muscle loss, a condition known as sarcopenia. Although direct evidence from human studies remains limited, positive results in animal studies are encouraging. This makes linoleic acid-rich oil a promising option for improving muscle health.12678
Who Is on the Research Team?
Martha Belury, PhD RDN
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for older adults with sarcopenia, which means they have lost muscle strength and mass. Participants will need to consume oil daily as part of the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume 12g of high linoleic safflower oil or high oleic safflower oil daily to assess changes in muscle strength, volume, fatigue resistance, and mobility
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- High Linoleic Acid Foods
- High Oleic Acid Foods
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator